Anaplastic Oligodendroglioma (AO) Recruiting Phase 1 Trials for Temozolomide (DB00853)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

IndicationStatusPhase
DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05698524A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent GliomaTreatment